Containment Measures and Eating Disorders (COVITA)

July 28, 2020 updated by: University Hospital, Montpellier

Impact of Containment Measures in People With Eating Disorders: a Descriptive Study

Since March 17, 2020, the French government has implemented national containment measures due to the COVID-19 epidemic. Quarantine is an unpleasant experience : Separation from relatives, loss of liberty, concern about the infectious status, boredom, can negatively affect mental health, with the emergence of anxiety and depressive symptoms.

In addition, confinement can disrupt usual physical activity, a major destabilization criterion for patients suffering from eating disorders (ED). Finally, conditions of confinement can harm social support, yet identified as a protective and resilience factor in stress contexts. Thus, the current context of confinement and social distances could be source of an increase in eating behavior disorders symptoms in people suffering from ED.

Study Overview

Status

Completed

Conditions

Detailed Description

Investigators will recruit 40 patients with eating disorders. All patients were initially assessed in the daily hospital of the Endocrinology, Diabetes, Nutrition Department (Montpellier University Hospital) from January to march 2020.

All participants will performed a phone interview to assess eating disorder symptoms, caracteristicus of containment, 1 month after the beginning of the containment, and 1 month after the end of the containment.

Study Type

Observational

Enrollment (Actual)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Montpellier, France, 34295
        • UHMontpellier

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients are adult women with a diagnostic of ED

Description

Inclusion criteria:

  • Adult women
  • Surferring from ED
  • Assessed in the ED daily hospital (UH of Montpellier) from January to March 2020

Exclusion criteria:

  • minors
  • refusal to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Variation in eating disorders
Time Frame: 1 month
the investigators aim to investigate the link between containment measures
1 month
Variation in eating disorders
Time Frame: 1 month
the investigators aim to investigate the link between ED symptomatology with EDE-Q (eating disorder evaluation, caractéristiques du TCA)
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Vision of the bodily aspect
Time Frame: 1 month
The investigators aim to investigate the link between containment measures
1 month
Vision of the bodily aspect
Time Frame: 1 month
The investigators aim to investigate the link between body dissatisfaction
1 month
Variation in physical activity
Time Frame: 1 month
the investigators aim to investigate the link between containment measures
1 month
Variation in physical activity
Time Frame: 1 month
the investigators aim to investigate the link between physical activity
1 month
Identify the clinical factors modulating the psychological state during confinement
Time Frame: 1 month
the investigators aim to investigate the link between containment measures
1 month
Identify the clinical factors modulating the psychological state during confinement
Time Frame: 1 month
the investigators aim to investigate the link between emotional eating
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Montpellier

Collaborators

INSERM U1061 (Statistics)

Investigators

  • Study Director: Ariane SULTAN, PR, University Hospital, Montpellier

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2020

Primary Completion (Actual)

May 30, 2020

Study Completion (Actual)

June 30, 2020

Study Registration Dates

First Submitted

April 19, 2020

First Submitted That Met QC Criteria

July 28, 2020

First Posted (Actual)

July 30, 2020

Study Record Updates

Last Update Posted (Actual)

July 30, 2020

Last Update Submitted That Met QC Criteria

July 28, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RECHMPL20_0220

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

NC

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COVID 19

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe